Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-10-002215
Filing Date
2010-03-15
Accepted
2010-03-15 17:09:06
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2197303z10-k.htm 10-K 844187
2 EX-3.2 a2197303zex-3_2.htm EX-3.2 120940
3 EX-4.2 a2197303zex-4_2.htm EX-4.2 28787
4 EX-23 a2197303zex-23.htm EX-23 3279
5 EX-31.1 a2197303zex-31_1.htm EX-31.1 8033
6 EX-31.2 a2197303zex-31_2.htm EX-31.2 8059
7 EX-32.1 a2197303zex-32_1.htm EX-32.1 4589
8 EX-32.2 a2197303zex-32_2.htm EX-32.2 4600
  Complete submission text file 0001047469-10-002215.txt   1024115
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 203823853 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-131722 | Film No.: 10682439
SIC: 2834 Pharmaceutical Preparations